The UAE administered third doses to a “small number” of people who did not develop antibodies to the coronavirus after the first two shots of Sinopharm, the National newspaper reported.
The UAE plans to offer a third shot of Sinopharm to people who already have two doses, amid concerns about the effectiveness of the vaccine that has been the cornerstone of the country’s rapid inoculation program.
“An additional dose of Sinopharm support is now available for people who have previously received the vaccine and have completed more than six months since the second dose,” said the National Crisis and Disaster Management Authority. ‘UAE Emergencies.
China’s Sinopharm Group Co. won the World Health Organization’s vaccine this month, but there are questions about how the shot, while protecting individuals from developing a severe Covid-19, can help prevent the virus from transmitting and infecting more people.
The UAE administered third doses to a “small number” of people who did not develop antibodies after the first two shots fired by Sinopharm, The National reported in March. The effectiveness of Sinopharm in preventing symptomatic and hospitalized diseases was estimated to be 79% in all age groups combined, the WHO said.
Other vaccine manufacturers also compete to develop booster shots. It is not yet clear when or if they will be needed, or who will get them if they are, but companies are preparing for a scenario where the virus continues to mutate and periodic booster shots may be needed.
Peng Xiao, CEO of G42, the company that fires Sinopharm locally in the UAE, told Bloomberg in March that the firm was “testing whether a third shot could help protect itself from the new mutations we see around us ”.
The UAE has one of the fastest vaccine launches in the world, as it has administered more than 11.5 million doses to its population of about 10 million. Infections have fallen by more than 65% since they peaked in January and the country saw the lowest increase in cases this year on Monday.
Vaccines from Pfizer Inc. and AstraZeneca Plc are approved for use, although the UAE’s inoculation program depends on Sinopharm, which is produced locally.
The Sinopharm trait accounts for approximately 60% of the doses administered in Seychelles, which has vaccinated more of its population than any other nation in the world, but has yet to reset some virus-related limits as cases increase.
The increase in the number of cases has raised concerns about effectiveness. Seychelles also uses the AstraZeneca vaccine.